Mapping gene-by-gene single-nucleotide variation in 8,535 Mycobacterium tuberculosis genomes: a resource to support potential vaccine and drug development by Papakonstantinou, D, Dunn, SJ, Draper, SJ, Cunningham, AF, O'Shea, MK, McNally, A

Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1 by Marini, A, Rossi, O, Aruta, MG, Micoli, F, Rondini, S, Guadagnuolo, S, Delany, I, Henderson, IR, Cunningham, AF, Saul, A, MacLennan, CA, Koeberling, O

Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease by Burel, JG, Singhania, A, Dubelko, P, Muller, J, Tanner, R, Parizotto, E, Dedicoat, M, Fletcher, TE, Dunbar, J, Cunningham, AF, Lindestam Arlehamn, CS, Catanzaro, DG, Catanzaro, A, Rodwell, T, McShane, H, O'Shea, MK, Peters, B

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface by Domínguez-Medina, CC, Pérez-Toledo, M, Schager, AE, Marshall, JL, Cook, CN, Bobat, S, Hwang, H, Chun, BJ, Logan, E, Bryant, JA, Channell, WM, Morris, FC, Jossi, SE, Alshayea, A, Rossiter, AE, Barrow, PA, Horsnell, WG, MacLennan, CA, Henderson, IR, Lakey, JH, Gumbart, JC, López-Macías, C, Bavro, VN, Cunningham, AF